References

1. Osterberg L and Blaschke T.  Adherence to Medication. N Engl J Med 2005; 353:487, August 4. 
2. García de Ollala P, Knobel H, Carmona A, Guelar A, López-Colomés JL, and Caylà JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of acquired immune deficiency syndromes 1999; 30(1): 105-110. 
3. Mille W, Powers K, Smith M, Cohen M. Community viral load as a measure for assessment of HIV treatment as prevention. The Lancet Infect Dis, 2013; 13(5): 459. 
4. García de Ollala P, Knobel H, Carmona A, Guelar A, López-Colomés JL, and Caylà JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of acquired immune deficiency syndromes 1999; 30(1): 105-110. 
5. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE. 2010;5:e11068 
6. El-Sadr W, Lundgren, JD, Neaton J, Gordin F, Abrams D, Arduino, R., . . . Cohen, C. CD4+ count-guided interruption of antiretroviral treatment. New Engl J Med 2006; 355(22): 2283-2296. 
7. Remien RH, Bauman LJ, Mantell JE, Tsoi B, Lopez-Rios J, Chhabra, R., . . . Teitelman, N. Barriers and facilitators to engagement of vulnerable populations in HIV primary care in New York City. JAIDS Journal of Acquired Immune Deficiency Syndromes 2015; 69: S16-S24. 
8. Mbuagbaw L, Sivaramalingam B, Navarro T, Hobson N, Keepanasseril A, Wilczynski NJ, Haynes RB. Interventions for Enhancing Adherence to Antiretroviral Therapy (ART): A Systematic Review of High-Quality Studies. AIDS Patient Care and STDs 2015; 29(5): 248-266. 
9. Mao L, Wit J, Kippax S, Prestage G, Holt, M. Younger age, recent HIV diagnosis, no welfare support, and no annual sexually transmissible infection screening are associated with nonuse of antiretroviral therapy among HIV‐positive gay men in Australia. HIV Medicine, 2015; 16(1): 32-37. 
10. HO. Patient monitoring guidelines for HIV care and antiretroviral therapy (ART). Geneva: WHO; 2006. 
11. INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fätkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 2015 Aug 27; 373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20. 
12. Grierson J, Koelmeyer RL,  Smith A, Pitts, M.  Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.  HIV Medicine 12; Issue 9:562–569, October. 
13. El-Sadr W, Lundgren, JD, Neaton J, Gordin F, Abrams D, Arduino, R., . . . Cohen, C. CD4+ count-guided interruption of antiretroviral treatment. New Engl J Med 2006; 355(22): 2283-2296. 
14. Langebeek N, Sprenger H, Gisolf E, Reiss P, Sprangers M, Legrand J, . . . Nieuwkerk P. A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial. HIV Medicine 2014; 15(5), 286‐290. 
15. O’Connor JL, Gardner EM, Mannheimer SB, Lifson A, Essex S, Telzah EE, Phillips AN for the INSIGHT SMART Study group. JID 2013:208:40-9. 
16. McMahon JH, Jordan MR, Kelley K, Bertagnolio S, Hong SY, Wanke CA, Lewin SR, Elliott JH. Pharmacy Adherence Measures to Assess Adherence to Antiretroviral Therapy: Review of the Literature and Implications for Treatment Monitoring. Clin Inf Di, 2011 Feb 15; 52; 4:493-506. doi: 10.1093/cid/ciq167. Epub 2011 Jan 18. 
17. Grierson J, Koelmeyer RL,  Smith A.  Pitts, M  Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.  HIV Medicine. 2011; 12(9):562–569, October. 
18. Barclay T, Hinkin C, Castellon S, Mason K, Reinhard M, Marion S, Levine A, Durvasula R. Age-Associated Predictors of Medication Adherence in HIV Positive Adults: Health Beliefs, Self-Efficacy, and Neurocognitive Status. Health Psychol 2007; 26(1): 40–49, January. doi:10.1037/0278-6133.26.1.40 
19. Bogart, L, Kalichman, SC and Simbayii, L. Endorsement of a genocidal HIV conspiracy as a barrier to HIV testing in South Africa. Journal of Acquired Immune Deficiency Syndromes, 2008; 49: 115-116. 
20. Wringe AR. Doubt, denial, and divine intervention: understanding delayed attendance and poor retention rates at an HIV treatment programme in rural Tanzania. AIDS Care, 2009; 21(5): 632-637. 
21. Sayles JN, Wong MD, Kinsler JJ, Martins D, Cunningham WE. The association of stigma with self-reported access to medical care and antiretroviral adherence in persons living with HIV/AIDS. Journal of General Internal Medicine 2009, October;  24:1101 
22. Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, Tsai AC. Impact of HIV-related stigma on treatment adherence: systematic review and meta-analysis. J Int AIDS Soc 2013; 16(3 Suppl 2): 18640. Doi: 10.7448/IAS. 16.3.18640. 
23. McAllister J  Beardsworth G, Lavie E, MacRae K, Carr A Financial stress is associated with reduced treatment adherence in HIV-infected adults in a resource-rich setting. HIV Med. 2013 Feb;14(2):120-4. doi: 10.1111/j.1468-1293.2012.01034.x. Epub 2012 Jul 10. 
25. Barclay T, Hinkin C, Castellon S, Mason K, Reinhard M, Marion S, Levine A, Durvasula R. Age-Associated Predictors of Medication Adherence in HIV Positive Adults: Health Beliefs, Self-Efficacy, and Neurocognitive Status. Health Psychol 2007; 26(1): 40–49, January. doi:10.1037/0278-6133.26.1.40 
26. Mellins C, Kang E,  Leu C-S, Havens J, Chesney M. AIDS Patient Care and STDs 2003, 17(8): 407-416, August. 
27. Lesserman, J. Role of Depression, Stress and Trauma in HIV Disease Progression. Psychosomatic Medicine. 2008 70 (5), 539-545, June. 
28. Reback CJ, Larkins S and Shoptaw S. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 2003; 15(6):775-85. 
29. Barclay T, Hinkin C, Castellon S, Mason K, Reinhard M, Marion S, Levine A, Durvasula R. Age-Associated Predictors of Medication Adherence in HIV Positive Adults: Health Beliefs, Self-Efficacy, and Neurocognitive Status. Health Psychol 2007; 26(1): 40–49, January. doi:10.1037/0278-6133.26.1.40 
30. Kalichman, SC, Ramachandran, C and Catz, S. Adherence to combination antiretroviral therapies in HIV seropositive men and women of low health literacy. Journal of General Internal Medicine. 1999; 14:267-273. 
31. Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care & STDs 2006; 20(5):359‐368. 
32. In a conversation with Judy Frecker (February 2016). 
33. Schnall RW. Feasibility testing of a web-based symptom self-management system for persons living with HIV. JANAC 2014; 25; 4:364-371. 
34. AIDS Info. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Limitations to Treatment Safety and Efficacy. Adherence to Antiretroviral Therapy (Last updated: May 1, 2014; last reviewed: May 1, 2014). 
35. Grossman CI, Stangl AL. Editorial: Global action to reduce HIV stigma and discrimination Article in Journal of the International AIDS Society 2013; 16(3)Suppl 2, November. 
36. Young, IM. Justice and the Politics of Difference. New Jersey: Princeton University Press. 1990. 
37. Cheek, J and Rudge, T. Been there, done that? Consciousness-raising, critical theory and nurses.  Contemporary Nurse, 1994; 3(2):58-63, June. 
38. Carcelero E, Tuset M, Martin M, De Lazzari E, Codina C, Miró J, Gatell J.HIV Med. Evaluation of antiretroviral-related errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients. 2011 Sep; 12(8):494-9. doi: 10.1111/j.1468-1293.2011.00915.x. Epub 2011 Mar 13. 
39. Faragon JJ. Antiretroviral medication errors in patients with HIV infection. University of Tennessee Advanced Studies in Pharmacy, 2006;3:5:179-186. 
40. Daniels LM, Durham C. Clinical Review:  Interventions to Prevent and Correct Antiretroviral Medication Errors in Patients with HIV. JCOM 2016; 23:1:13-21. 
41. Commers T, Swindell S, Sayles H, Gross AE, Devetten M ,Sandovsky U. Antiretroviral medication prescribing errors are common with hospital admission of HIV-infected patients. J Antimicrob Chemother 2014; Jan; 69(1):262-7. doi: 10.1093/jac/dkt323. Epub 2013 Aug 16. 
42. Duguld M The importance of medication reconciliation for patients and practitioners. Australian Prescriber 2012; 35; 1:15-19, February. 
43. El-Sadr W, Lundgren, JD, Neaton J, Gordin F, Abrams D, Arduino, R., . . . Cohen, C. CD4+ count-guided interruption of antiretroviral treatment. New Engl J Med 2006; 355(22): 2283-2296 
44. Langebeek N, Sprenger H, Gisolf E, Reiss P, Sprangers M, Legrand J, . . . Nieuwkerk P. A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial. HIV Medicine 2014; 15(5), 286‐290. 
45. Lifson A, Grandits G, Gardner E, Wolff M, Pulik P, Williams I, Barman W. Quality of life assessment among HIV‐positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Medicine 2015; 16(S1): 88-96. 
46. Molina, J., Capitant, C., Charreau, I., Meyer, L., Spire, B., & Pialoux, G. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial. Paper presented at the Conference on Retroviruses and Opportunistic Infections. Seattle, WA, 2015.